Thymosin alpha-1 clinical trials: 19 trials
Page 1 of 1
Read 19 Thymosin alpha-1 clinical trials with posted results or linked papers with results in PepBank.
- The Efficacy and Safety of Ta1 for Sepsis
NCT02867267 · Phase 3 · Completed
Linked paper with results
- Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
NCT01943617 · Phase 4 · Completed
Linked paper with results
- Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.
NCT01178996 · Phase 3 · Completed
Linked paper with results
- Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
NCT02473406 · Phase 4 · Completed
Linked paper with results
- Thymosin-α1 for Recurrent Implantation Failure
NCT07675980 · Phase 2/3 · Recruiting
Linked paper with results
- Thymosin Alpha-1 for irAE Secondary to ICIs
NCT06178146 · Phase 4 · Status unknown
Linked paper with results
- Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
NCT00911443 · Phase 2 · Completed
Posted results
- Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
NCT04428008 · Phase 2 · Completed
Posted results
- The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
NCT06139419 · Phase 2 · Completed
Linked paper with results
- Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer
NCT03659578 · Phase 2 · Completed
Linked paper with results
- Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
NCT05790447 · Phase 2 · Status unknown
Linked paper with results
- Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
NCT04487444 · Phase 2 · Terminated
Linked paper with results
- Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
NCT07644897 · Phase 2 · Recruiting
Linked paper with results
- Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06461910 · Phase 2 · Recruiting
Linked paper with results
- Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT06056804 · Phase 2 · Active, not recruiting
Linked paper with results
- Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
NCT02646189 · Phase 1/2 · Completed
Linked paper with results
- Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
NCT04963712 · Early phase 1 · Completed
Linked paper with results
- The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
NCT00001036 · Phase 1 · Completed
Linked paper with results
- Efficacy of Thymosin alpha1 for Severe Sepsis
NCT00711620 · Not applicable · Completed
Linked paper with results